Skip links
Companies
› United States › HAEMONETICS CORPORATION
Company registry profile

HAEMONETICS CORPORATION

Public Limited Company Active

in

HAEMONETICS CORPORATION is a Public Limited Company registered in United States under 042882273, and its current status with Massachusetts Secretary of the Commonwealth is active. The company was incorporated on 29 August 1985 and lists its registered address as United States. 6 shareholders are on record for HAEMONETICS CORPORATION, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Massachusetts Secretary of the Commonwealth and was last updated on 25 September 2026.

From the registry

Registration details

Registration No.
042882273
Incorporation Date
1985-08-29
Company Type
Public Limited Company
Address
United States
Website
www.haemonetics.com/
Source: Massachusetts Secretary of the CommonwealthRegistry coverage

Shareholders

6

Shareholders of HAEMONETICS CORPORATION

Six shareholders are currently on record for HAEMONETICS CORPORATION, reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 13.9% — the largest recorded stake — followed by iShares Trust-iShares Core S&P Mid-Cap ETF at 4.3%; the remaining 4 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Swipe or scroll for more columns

Shareholder Type Holding Source Document
Vanguard Group Inc 13.9% Massachusetts Secretary of the Commonwealth
iShares Trust-iShares Core S&P Mid-Cap ETF 4.3% Massachusetts Secretary of the Commonwealth
NEUBERGER BERMAN EQUITY FUNDS-Neuberger Berman Genesis Fund 4.1% Massachusetts Secretary of the Commonwealth

Officers

34

Directors and officers of HAEMONETICS CORPORATION

The Ceo of HAEMONETICS CORPORATION currently on record is Christopher Simon; 34 officers are currently on record for HAEMONETICS CORPORATION, filed with Massachusetts Secretary of the Commonwealth. Management authority at HAEMONETICS CORPORATION sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

CS
Christopher Simon ACTIVE

Residence
🇺🇸 United States
Occupation
Ceo

CA
Christopher A. Simon ACTIVE

Residence
🇺🇸 United States
Occupation
Ceo, President & Director

RA
Robert Abernathy ACTIVE

Residence
🇺🇸 United States
Occupation
Director

CD
Charles Dockendorff ACTIVE

Residence
🇺🇸 United States
Occupation
Director

DB
Diane Bryant ACTIVE

Residence
🇺🇸 United States
Occupation
Director

OG
Olga Guyette ACTIVE

Residence
🇺🇸 United States
Occupation
Senior Director Of Investor Relations

MK
Mark Kroll ACTIVE

Residence
🇺🇸 United States
Occupation
Director

EZ
Ellen Zane ACTIVE

Residence
🇺🇸 United States
Occupation
Director

CP
Claire Pomeroy ACTIVE

Residence
🇺🇸 United States
Occupation
Director

LJ
Lloyd Johnson ACTIVE

Residence
🇺🇸 United States
Occupation
Director

MC
Michael Coyle ACTIVE

Residence
🇺🇸 United States
Occupation
Director

CT
C T Corporation System ACTIVE ENTITY

Residence
🇺🇸 United States
Occupation
Agent

SW
Stewart W. Strong ACTIVE

Residence
🇺🇸 United States
Occupation
President Of Global Hospital

LA
Laurie A. Miller ACTIVE

Residence
🇺🇸 United States
Occupation
Senior Vp & Chief Human Resources Officer

RG
Roy Galvin ACTIVE

Residence
🇺🇸 United States
Occupation
Executive Vp & Chief Commercial Officer

TP
Thomas Powers ACTIVE

Residence
🇺🇸 United States
Occupation
Assistant Secretary

JD
James D'arecca ACTIVE

Residence
🇺🇸 United States
Occupation
Vice President

CS
Christopher Simon ACTIVE

Residence
🇺🇸 United States
Occupation
President

KD
Kerri Dipietro ACTIVE

Residence
🇺🇸 United States
Occupation
Senior Vice President Of Global Quality Assurance

JH
Jan Hartmann M.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Senior Vp & Chief Medical Officer

FW
Frank W. Chan Ph.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Executive Vp & Coo

JD
James D'arecca ACTIVE

Residence
🇺🇸 United States
Occupation
Cfo

RV
Rajeev Varma ACTIVE

Residence
🇺🇸 United States
Occupation
Senior Vice President Of Strategy & Corporate Development

AL
Anila Lingamneni ACTIVE

Residence
🇺🇸 United States
Occupation
Executive Vp & Cto

JL
Josep Llorens ACTIVE

Residence
🇺🇸 United States
Occupation
Executive Vice President Of Global Manufacturing & Supply Chain

JD
James D'arecca ACTIVE

Residence
🇺🇸 United States
Occupation
Treasurer

DJ
David J. Wilson ACTIVE

Residence
🇺🇸 United States
Occupation
President Of Plasma Business Unit

OG
Olga Guyette ACTIVE

Residence
🇺🇸 United States
Occupation
Assistant Treasurer

JC
James C. D'arecca Cpa ACTIVE

Residence
🇺🇸 United States
Occupation
Cfo, Executive Vp & Financial Officer

FM
Farris Maryanne Maunsell ACTIVE

Residence
🇺🇸 United States
Occupation
Vp, Chief Accounting Officer & Principal Accounting Officer

ML
Michelle L. Basil ACTIVE

Residence
🇺🇸 United States
Occupation
Executive Vp, General Counsel & Secretary

ML
Michelle L. Basil ACTIVE

Residence
🇺🇸 United States
Occupation
Secretary

ML
Michelle L. Basil Esq., J.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Executive Vp, General Counsel & Secretary

ML
Michelle L. Basil J.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Executive Vp, General Counsel & Secretary

Group Structure

Group structure of HAEMONETICS CORPORATION

HAEMONETICS CORPORATION has no recorded parent company — it sits at the top of its own group structure, with 29 subsidiaries recorded beneath it across 12 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

  • Haemonetics Manufacturing, Inc. (United States)
  • HAEMONETICS JAPAN GK (Japan)
  • enicor GmbH (Germany)
  • Arryx Inc (United States)
  • HAEMONETICS FRANCE (France)
  • HAEMONETICS ASIA UK LTD (United Kingdom)
  • HEMONETIKS KOREA CO.,LTD. (South Korea)
  • Haemonetics Handelsgesellschaft m.b.H. (Austria)
  • Haemoscope Corporation (United States)
  • Global Med Technologies, Inc. (United States)

Data availability

Those 29 subsidiaries span United States, Japan, Germany, France, United Kingdom, South Korea, and 6 more jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Six of the 29 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.

Top of recorded group
HAEMONETICS CORPORATION
United States
Haemonetics Manufacturing, Inc.+ subsidiaries
United StatesUS CA 5151435

HAEMONETICS JAPAN GK
JapanJP 9010003015275

enicor GmbH
GermanyDE 80333B247526

Arryx Inc
United StatesUS IL 364404953

HAEMONETICS FRANCE
FranceFR 31185239600044

HAEMONETICS ASIA UK LTD+ subsidiaries
United KingdomGB 08047857

HEMONETIKS KOREA CO.,LTD.
South KoreaKR 1208703049

Haemonetics Handelsgesellschaft m.b.H.
AustriaAT FN140775y

+21 more entities

Registry questions

Frequently asked questions

Who owns HAEMONETICS CORPORATION?

Six shareholders are currently on record for HAEMONETICS CORPORATION, reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 13.9% — the largest recorded stake — followed by iShares Trust-iShares Core S&P Mid-Cap ETF at 4.3%; the remaining 4 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is HAEMONETICS CORPORATION's UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for HAEMONETICS CORPORATION is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does HAEMONETICS CORPORATION have on record?

6 shareholders are shown on record for HAEMONETICS CORPORATION.

What is HAEMONETICS CORPORATION's company registration number?

HAEMONETICS CORPORATION's registration number is 042882273, filed with Massachusetts Secretary of the Commonwealth in United States. Its current status on the register is active.

Is HAEMONETICS CORPORATION still an active company?

HAEMONETICS CORPORATION's status on Massachusetts Secretary of the Commonwealth is listed as active.

When was HAEMONETICS CORPORATION incorporated?

HAEMONETICS CORPORATION was incorporated on 29 August 1985, according to Massachusetts Secretary of the Commonwealth.

What is HAEMONETICS CORPORATION's registered address?

The registered address on file for HAEMONETICS CORPORATION is United States.

What legal structure is HAEMONETICS CORPORATION registered as?

HAEMONETICS CORPORATION is registered as a Public Limited Company in United States.

Who are the officers/directors of HAEMONETICS CORPORATION?

The Ceo of HAEMONETICS CORPORATION currently on record is Christopher Simon; 34 officers are currently on record for HAEMONETICS CORPORATION, filed with Massachusetts Secretary of the Commonwealth. Management authority at HAEMONETICS CORPORATION sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does HAEMONETICS CORPORATION have a parent company or subsidiaries?

HAEMONETICS CORPORATION has no recorded parent company — it sits at the top of its own group structure, with 29 subsidiaries recorded beneath it across 12 jurisdictions. Those 29 subsidiaries span United States, Japan, Germany, France, United Kingdom, South Korea, and 6 more jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Six of the 29 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.

Can Zavia monitor changes to HAEMONETICS CORPORATION's ownership over time?

This profile reflects a point-in-time snapshot from Massachusetts Secretary of the Commonwealth. Zavia's monitoring API can track changes to HAEMONETICS CORPORATION's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access HAEMONETICS CORPORATION's data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like HAEMONETICS CORPORATION's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from Massachusetts Secretary of the Commonwealth and was last synced on 25 September 2026.

This website uses cookies to improve your web experience.